What does DR PROUMEN OPHTALMOLOGIE do?

DR PROUMEN OPHTALMOLOGIE is a specialist medical practice in Marche-en-Famenne. Private Limited, started on 29 January 2021, 1 establishment.

What is the address of DR PROUMEN OPHTALMOLOGIE?

The registered office of DR PROUMEN OPHTALMOLOGIE is located at Marche, Avenue de la Toison d'Or 156, 6900 Marche-en-Famenne.

Is DR PROUMEN OPHTALMOLOGIE still active?

Yes. According to the CBE (18 September 2026) DR PROUMEN OPHTALMOLOGIE is active, legal situation “Normale toestand”, started on 29 January 2021.

Is DR PROUMEN OPHTALMOLOGIE registered on Peppol?

No, DR PROUMEN OPHTALMOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DR PROUMEN OPHTALMOLOGIE?

The enterprise number of DR PROUMEN OPHTALMOLOGIE is BE0762666755.

When was DR PROUMEN OPHTALMOLOGIE founded?

DR PROUMEN OPHTALMOLOGIE was founded on 29 January 2021.

Who are the directors of DR PROUMEN OPHTALMOLOGIE?

According to the 2024 annual accounts, the directors of DR PROUMEN OPHTALMOLOGIE are: Xavier PROUMEN.

Is DR PROUMEN OPHTALMOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 January 2021; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DR PROUMEN OPHTALMOLOGIE make in 2024?

DR PROUMEN OPHTALMOLOGIE posted a profit after taxes of € 664,940 in financial year 2024.

What is the revenue of DR PROUMEN OPHTALMOLOGIE?

As a small company, DR PROUMEN OPHTALMOLOGIE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 977,568.

DR PROUMEN OPHTALMOLOGIE (Private Limited)

Dossier DR PROUMEN OPHTALMOLOGIE, printed on 18 September 2026 from databakkes.be/en/0762666755/dr-proumen-ophtalmologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

DR PROUMEN OPHTALMOLOGIE from Marche-en-Famenne, company number BE0762666755, closed financial year 2024 with a result of € 664,940 after tax. For that financial year DR PROUMEN OPHTALMOLOGIE recorded a gross margin of € 977,568 and equity of € 1.3 million. Compared with financial year 2023, the result moved from € 593,275 to € 664,940. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 3, 2025.

What it is worth Healthy

€ 1.3 million

▼ 6% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 664,940

▲ 12% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 632,286

▲ € 580,409 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 744,176 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 536

▼ 75% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 311,617

▼ 17% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 422,135 Gross margin 2021: € 422,135 First fiscal year in the series	€ 662,276 Gross margin 2022: € 662,276 ▲ 57% vs 2021 (€ 422,135) Favourable step	€ 776,693 Gross margin 2023: € 776,693 ▲ 17% vs 2022 (€ 662,276) Favourable step	€ 977,568 Gross margin 2024: € 977,568 ▲ 26% vs 2023 (€ 776,693) Favourable step	▲ 26%
Profit after taxes	€ 320,380 Profit after taxes 2021: € 320,380 First fiscal year in the series	€ 495,360 Profit after taxes 2022: € 495,360 ▲ 55% vs 2021 (€ 320,380) Favourable step	€ 593,275 Profit after taxes 2023: € 593,275 ▲ 20% vs 2022 (€ 495,360) Favourable step	€ 664,940 Profit after taxes 2024: € 664,940 ▲ 12% vs 2023 (€ 593,275) Favourable step	▲ 12%
Equity	€ 323,380 Equity 2021: € 323,380 First fiscal year in the series	€ 818,740 Equity 2022: € 818,740 ▲ 153% vs 2021 (€ 323,380) Favourable step	€ 1,412,015 Equity 2023: € 1,412,015 ▲ 72% vs 2022 (€ 818,740) Favourable step	€ 1,332,778 Equity 2024: € 1,332,778 ▼ 6% vs 2023 (€ 1,412,015) Unfavourable step	▼ 6%
Total debts	€ 121,552 Total debts 2021: € 121,552 First fiscal year in the series	€ 306,416 Total debts 2022: € 306,416 ▲ 152% vs 2021 (€ 121,552) Unfavourable step	€ 386,671 Total debts 2023: € 386,671 ▲ 26% vs 2022 (€ 306,416) Unfavourable step	€ 443,446 Total debts 2024: € 443,446 ▲ 15% vs 2023 (€ 386,671) Unfavourable step	▲ 15%
Cash	€ 381,846 Cash 2021: € 381,846 First fiscal year in the series	€ 1,003,138 Cash 2022: € 1,003,138 ▲ 163% vs 2021 (€ 381,846) Favourable step	€ 51,877 Cash 2023: € 51,877 ▼ 95% vs 2022 (€ 1,003,138) Unfavourable step	€ 632,286 Cash 2024: € 632,286 ▲ € 580,409 vs 2023 (€ 51,877) Favourable step	▲ € 580,409
Retained profit	€ 320,380 Retained profit 2021: € 320,380 First fiscal year in the series	€ 815,740 Retained profit 2022: € 815,740 ▲ 155% vs 2021 (€ 320,380) Favourable step	€ 1,409,015 Retained profit 2023: € 1,409,015 ▲ 73% vs 2022 (€ 815,740) Favourable step	€ 1,329,778 Retained profit 2024: € 1,329,778 ▼ 6% vs 2023 (€ 1,409,015) Unfavourable step	▼ 6%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 744,176 Dividend 2024: € 744,176 Unchanged (€ 0) Unchanged
Balance sheet total	€ 444,933 Balance sheet total 2021: € 444,933 First fiscal year in the series	€ 1,125,156 Balance sheet total 2022: € 1,125,156 ▲ 153% vs 2021 (€ 444,933) Unchanged	€ 1,798,686 Balance sheet total 2023: € 1,798,686 ▲ 60% vs 2022 (€ 1,125,156) Unchanged	€ 1,776,224 Balance sheet total 2024: € 1,776,224 ▼ 1% vs 2023 (€ 1,798,686) Unchanged	▼ 1%

Key figures of DR PROUMEN OPHTALMOLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR PROUMEN OPHTALMOLOGIE?

What happened at DR PROUMEN OPHTALMOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 3, 2025 New annual accounts for financial year 2024: profit of € 664,940 (▲ 12% vs 2023). filed late Source: NBB ↗
Jan 29, 2021 New establishment in Andenne. KBO
Jan 29, 2021 Start of the company according to the CBE. KBO

In short

From € 320,380 profit in 2021 to € 664,940 profit in 2024.

Paid € 745,707 in corporate taxes since 2021.

Best year ever: 2024, with € 664,940 profit.

Paid out € 744,176 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR PROUMEN OPHTALMOLOGIE? We notify you, reason included.

Follow DR PROUMEN OPHTALMOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Xavier PROUMEN

DR PROUMEN OPHTALMOLOGIE

Behind DR PROUMEN OPHTALMOLOGIE is Xavier PROUMEN.

See the full network in the app

Directors

According to the 2024 annual accounts

Xavier PROUMEN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Marche, Avenue de la Toison d'Or 156

6900 Marche-en-Famenne

2.316.253.793

Froidebise 1 box A

5300 Andenne

Active since 29 January 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.666.755
VAT number: BE 0762.666.755
Registered office: Marche, Avenue de la Toison d'Or 156, 6900 Marche-en-Famenne
Names & denominations: DR PROUMEN OPHTALMOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 January 2021
Peppol: Not registered
Contact: [email protected]
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗